SCHEMBL5520660

SCHEMBL5520660

CCCCCCCCCCCCCCCCCCN1C=CN(C)C1C(F)(F)C(F)(F)S(=O)(=O)O

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.33
CES1 P23141 5/20 0.31
FAAH O00519 3/20 0.31
CES2 O00748 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5518392 1.00 EPHX1 (0.33) EPHX1CES1FAAHCES2
SCHEMBL5514602 1.00 EPHX1 (0.33) EPHX1CES1FAAHCES2
SCHEMBL5521108 1.00 EPHX1 (0.33) EPHX1CES1FAAHCES2
SCHEMBL5514427 0.94
SCHEMBL5518366 0.84
SCHEMBL358540 0.78
Trifluoromethanesulfonic Acid SCHEMBL28576066 0.78 EPHX1 (0.37) EPHX1CES1FAAHCES2
Trifluoromethanesulfonic Acid SCHEMBL30298740 0.78 EPHX1 (0.37) EPHX1CES1FAAHCES2
Trifluoromethanesulfonic Acid SCHEMBL28475024 0.78 EPHX1 (0.37) EPHX1CES1FAAHCES2
Trifluoromethanesulfonic Acid SCHEMBL28568048 0.78 EPHX1 (0.37) EPHX1CES1FAAHCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070100181-A1 Olefin isomerization E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-03 US claimed
US-20070100181-A1 Olefin isomerization E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070100181-A1 Olefin isomerization OSBP, OXER1, ALOX12 EPHX1 568/4885CES1 1829/4885FAAH 280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.